← All trials
NCT00030758
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2001
- Primary completion
- —
- Completion date
- —
- First posted
- —
- Last posted
- —
- Enrollment
- 816
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- Anglo Celtic Cooperative Oncology GroupLead sponsor
- Charing Cross HospitalStudy chair
- Scottish Cancer Therapy NetworkStudy chair
- Scottish Cancer Therapy NetworkCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.